Emirates Oncology Society (EOS) shared on LinkedIn:
“Join EOS for an impactful meeting on Reconsidering the Reflex Action in Treatment for EGFR- Mutated NSCLC!
Date: Tuesday, 20 October 2026, Virtual, 2 CME Hours.
Time: UAE: 07:00 PM, London: 04:00 PM, NY: 11:00 AM, Kuwait: 06:00 PM, Qatar: 06:00 PM.
Moderator: Dr. Hassan Jaafar.
Speakers: Dr. Emad Dawoud, Dr. Dina Hamza, Dr. Dalia Elshorbagy, Dr. Hassan Shahrayr, Dr. Syed Karim.
Endorsed by: Emirates Oncology Society (EOS) and Emirates Medical Association (EMA).
Sponsored by: Johnson and Johnson.
Managed by: Conveners.”
Reconsidering the Reflex Action in Treatment for EGFR-Mutated NSCLC.
You can also read: AENEAS2: Aumolertinib Plus Chemotherapy Extends PFS in EGFR-Mutant Advanced NSCLC.
